Literature DB >> 25648558

Estimated glomerular filtration rate leads to higher drug dose recommendations in the elderly compared with creatinine clearance.

J Q Hudson1, J R Bean, C F Burger, A K Stephens, M S McFarland.   

Abstract

PURPOSE: The elderly are at risk for adverse drug events because of inappropriate dosing of renally eliminated medications. The purpose of this study was to evaluate differences in estimates of kidney function and recommended doses of select medications in the elderly using the Modification of Diet in Renal Disease (MDRD) or the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations compared with the Cockcroft-Gault (CG) equation.
METHODS: Patients 65 years of age and older were included in this retrospective, observational analysis. Kidney function was estimated by CG, MDRD and CKD-EPI equations for all patients and by age category (65-69, 70-79, 80-89 and 90-100 years). Differences in estimates and dosing of allopurinol, enoxaparin, gabapentin, piperacillin/tazobactam and sulfamethoxazole/trimethoprim using the MDRD and CKD-EPI compared with the CG were assessed.
RESULTS: In the 4160 patients (98% male, mean age 74 ± 7 years), the MDRD and CKD-EPI estimates were significantly higher than CG estimates for all patients and by age category (p < 0.001). Dosing discordance was predominantly because of a higher dose recommended by MDRD and CKD-EPI estimates compared with CG. Discordance was highest with gabapentin (27%), the medication with the greatest number of dosing stratifications by estimated kidney function, and increased by 66% from the youngest to the oldest age category.
CONCLUSIONS: Until newer equations are used uniformly to develop dosing nomograms, it is prudent to adopt a process for drug dosing in the elderly that is more conservative than eGFR based dosing, but that considers the potential for underestimating kidney function with the CG equation.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25648558     DOI: 10.1111/ijcp.12532

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma.

Authors:  Meletios A Dimopoulos; Matthew C Cheung; Murielle Roussel; Ting Liu; Barbara Gamberi; Brigitte Kolb; H Guenter Derigs; HyeonSeok Eom; Karim Belhadj; Pascal Lenain; Richard Van der Jagt; Sophie Rigaudeau; Mamoun Dib; Rachel Hall; Henry Jardel; Arnaud Jaccard; Axel Tosikyan; Lionel Karlin; William Bensinger; Rik Schots; Nicolas Leupin; Guang Chen; Jennifer Marek; Annette Ervin-Haynes; Thierry Facon
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

Review 2.  The conundrums of chronic kidney disease and aging.

Authors:  Richard J Glassock; Aleksandar Denic; Andrew D Rule
Journal:  J Nephrol       Date:  2016-11-25       Impact factor: 3.902

3.  Development and Application of the GheOP3S-Tool Addendum on Potentially Inappropriate Prescribing (PIP) of Renally Excreted Active Drugs (READs) in Older Adults with Polypharmacy.

Authors:  Abdul Aziz Al Wazzan; Eline Tommelein; Katrien Foubert; Stefano Bonassi; Graziano Onder; Annemie Somers; Mirko Petrovic; Koen Boussery
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

4.  Correlation of Measured and Estimated Creatinine Clearance in Hospitalized Elderly Patients: A Retrospective Cohort Study.

Authors:  Rachel I Lavelle; Austin R Brown; Anthony Gerlach
Journal:  Hosp Pharm       Date:  2020-05-17

5.  Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.

Authors:  Anders Helldén; Fadiea Al-Aieshy; Pia Bastholm-Rahmner; Ulf Bergman; Lars L Gustafsson; Hans Höök; Susanne Sjöviker; Anders Söderström; Ingegerd Odar-Cederlöf
Journal:  BMJ Open       Date:  2015-07-06       Impact factor: 2.692

6.  Discordance of renal drug dosing using estimated creatinine clearance and measured urine creatinine clearance in hospitalized adults: A retrospective cohort study.

Authors:  Austin R Brown; Rachel I Lavelle; Anthony T Gerlach
Journal:  Int J Crit Illn Inj Sci       Date:  2020-09-16

7.  Design, development, and deployment of an indication- and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors.

Authors:  Jamie S Hirsch; Rajdeep Brar; Christopher Forrer; Christine Sung; Richard Roycroft; Pradeep Seelamneni; Hemala Dabir; Ambareen Naseer; Pranisha Gautam-Goyal; Kevin R Bock; Michael I Oppenheim
Journal:  JAMIA Open       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.